Dose Of PGF2α Research Articles

Comparison of synchronisation and fertility after different modifications of the ovsynch protocol in cyclic dairy cows

The objectives of this study were to evaluate the effects of (1) double doses of PGF2α administration or (2) an exogenous progesterone (CIDR) applied concurrently with, or (3) the day after, first GnRH of Ovsynch (GnRH-1), on synchronisation and fertility during the Ovsynch protocol. All cows (n = 378) received the Ovsynch protocol (GnRH-7d-PGF2α-56h-GnRH-18h-TAI). The 'OVS' group (n = 105) received only the Ovsynch protocol. The 'OVS-PGF' group (n = 118, GnRH-7d-PGF2α-12h-PGF2α-44h-GnRH-18h-TAI) received an extra dose of PGF2α 12 h later on Day 7. The 'OVS-7CIDR' group (n = 78, GnRH+CIDR-7d-PGF2α-56h-GnRH-18h-TAI) received a CIDR for 7 days between GnRH-1 and PGF2α. In the 'OVS-6CIDR' group (n = 77, GnRH-24h-CIDR-6d-PGF2α-56h-GnRH-18h-TAI), CIDR was applied one day after GnRH-1 and removed 6 days later. When all cows were evaluated, the responses to GnRH-2 were higher (P = 0.005) in cows that responded to GnRH-1 (95.4%) compared to the cows that did not respond (87.6%). The pregnancy rates at 31 and 62 days for each group were 48.6% and 42.9% in the OVS, 54.2% and 52.5% in the OVS-PGF, 52.6% and 48.7% in the OVS-7CIDR, and 55.8% and 49.3% in the OVS-6CIDR groups. Thus, none of the three different treatments has an effect on increasing the out-comes of the Ovsynch protocol in cyclic lactating dairy cows.

Effect of the first GnRH and two doses of PGF2α in a 5-day progesterone-based CO-Synch protocol on heifer pregnancy

The objectives were (1) to determine the effects of gonadorelin hydrochloride (GnRH) injection at controlled internal drug release (CIDR) insertion on Day 0 and the number of PGF2α doses at CIDR removal on Day 5 in a 5-day CO-Synch + CIDR program on pregnancy rate (PR) to artificial insemination (AI) in heifers; (2) to examine how the effect of systemic concentration of progesterone and size of follicles influenced treatment outcome. Angus cross beef heifers (n = 1018) at eight locations and Holstein dairy heifers (n = 1137) at 15 locations were included in this study. On Day 0, heifers were body condition scored (BCS), and received a CIDR. Within farms, heifers were randomly divided into two groups: at the time of CIDR insertion, the GnRH group received 100 μg of GnRH and No-GnRH group received none. On Day 5, all heifers received 25 mg of PGF2α at the time of CIDR insert removal. The GnRH and No-GnRH groups were further divided into 1PGF and 2PGF groups. The heifers in 2PGF group received a second dose of PGF2α 6 hours after the administration of the first dose. Beef heifers underwent AI at 56 hours and dairy heifers at 72 hours after CIDR removal and received 100 μg of GnRH at the time of AI. Pregnancy was determined approximately at 35 and/or 70 days after AI. Controlling for herd effect (P < 0.06), the treatments had significant effect on AI pregnancy in beef heifers (P = 0.03). The AI-PRs were 50.3%, 50.2%, 59.7%, and 58.3% for No-GnRH + PGF + GnRH, No-GnRH + 2PGF + GnRH, GnRH + PGF + GnRH, and GnRH + 2PGF + GnRH groups, respectively. The AI-PRs were ranged from 50% to 62.4% between herds. Controlling for herd effects (P < 0.01) and for BCS (P < 0.05), the AI pregnancy was not different among the treatment groups in dairy heifers (P > 0.05). The AI-PRs were 51.2%, 51.9%, 53.9%, and 54.5% for No-GnRH + PGF + GnRH, No-GnRH + 2PGF + GnRH, GnRH + PGF + GnRH, and GnRH + 2PGF + GnRH groups, respectively. The AI-PR varied among locations from 48.3% to 75.0%. The AI-PR was 43.5%, 50.4%, and 64.2% for 2.5 or less, 2.75 to 3.5, and greater than 3.5 BCS categories. Numerically higher AI-PRs were observed in beef and dairy heifers that exhibited high progesterone concentrations at the time of CIDR insertion (>1 ng/mL, with a CL). In addition, numerically higher AI-PRs were also observed in heifers receiving CIDR + GnRH with both high and low progesterone concentration (<1 ng/mL) initially compared with heifers receiving a CIDR only with low progesterone. In dairy heifers, there were no differences in the pregnancy loss between 35 and 70 days post-AI among the treatment groups (P > 0.1). In conclusion, GnRH administration at the time of CIDR insertion is advantageous in beef heifers, but not in dairy heifers, to improve AI-PR in the 5-day CIDR + CO-Synch protocol. In addition, in this study, both dairy heifers that received either one or two PGF2α doses at CIDR removal resulted in similar AI-PR in this study regardless of whether they received GnRH at CIDR insertion.

Detection of estrous behavior in buffalo heifers by radiotelemetry following PGF2α administration during the early or late luteal phase

This study examined the usefulness of radiotelemetry for estrous detection in buffalo heifers and the impact of prostaglandin F2α (PGF2α) administration during the early or late luteal phase on estrous behavior and ovulatory follicle variables. Induction of estrus with PGF2α at a random stage of the estrous cycle was followed by the arbitrary division of heifers into groups receiving a second dose of PGF2α during either the early (n=33) or late (n=17) luteal phase (6–9 or 11–14 days after estrus, respectively) for the induction of synchronized estrus. The electronic detection of synchronized estrus by radiotelemetry was confirmed using ultrasonography every 6h until ovulation. Radiotelemetry was 90% efficient and 100% accurate for estrous detection. Intervals between the PGF2α dose and the beginning of synchronized estrus (40.7±10.9 vs. 56.7±12.8h) or ovulation (70.0±11.3 vs. 85.6±12.5h) were shorter (P<0.05) for heifers receiving PGF2α during the early luteal phase. PGF2α administration during the early or late luteal phase produced similar (P>0.05) results for the duration of estrus, the intervals from the beginning or end of estrus to ovulation, the number and duration of mounts per estrus, the duration of mounts, the diameter of the ovulatory follicle and the luteal profile on day 5 after estrus. In conclusion, radiotelemetry was a suitable tool for the efficient and accurate detection of estrus in buffalo heifers. Treatment with PGF2α during the early luteal phase had a shorter interval to synchronized estrus and ovulation; however, estrous behavior, ovulatory follicle dynamics and subsequent luteal activity were similar following PGF2α administration during the early or late luteal phase.

112 OVARIAN FOLLICLE RESERVE IN NELLORE AND ANGUS HEIFERS WITH LOW AND HIGH FOLLICLE COUNT

Cattle from Bos indicus breeds recruit and develop more follicles per oestrous cycle compared with cattle from Bos taurus breeds. The number of antral follicles in the ovaries is a decisive factor for the success of reproductive technologies such as ovum pick-up and embryo transfer. The reasons why indicine cattle recruit and develop more follicles are not known. Our objectives were to evaluate the ovarian reserve of Nellore and Angus heifers and determine at which stage of follicle development Nellor ovarian reserve differs from Angus ovarian reserve. To determine if animals were in the low or high follicle count group (LFC or HFC), antral follicles (≥3 mm) were scanned with an ultrasound device (US; Mindray Vet DPS 2200, Sao Paulo, Brazil) equipped with a 7.5-MHz probe Day 1 after ovulation (Day 0) for 3 consecutive oestrous cycles. Eighteen Nellore heifers (11 LFC and 7 HFC) and 25 Angus heifers (12 LFC and 13 HFC) were used in the experiment. Oestrous cycles were synchronized with 2 doses of PGF2α ± 11 days apart. Animals were slaughtered ~24 h after ovulation of the third oestrous cycle. Ovulation was determined by oestrous observation, absence of the dominant follicle on the ultrasound, and presence of the corpus luteum after slaughter. One ovary from each animal was used for histology. The ovary was sliced longitudinally in 6 parts, fixed in 10% paraformaldehyde for 24 h, and stored in 70% ethanol until processing. Two longitudinal slices were blocked in paraffin. One section (8 μm thick) was stained after every 50 sections, totaling 10 sections per longitudinal slice of ovarian tissue. Sections were stained using eosin and hematoxylin. Follicles were counted and classified under a stereo microscope with a 40× objective; only follicles with a visible nucleus were counted. Follicles were classified as primordial, primary, and secondary. The area of each section was measured using the hand tool on the ImageJ software. Area measurements were expressed as pixels squared. The density of each follicle classification was calculated as follicle/log10 [pixel2]. Data were analysed using PROC GLM procedure of SAS 9.2 considering the effects of breed and group (LFC or HFC). Angus heifers had more primordial follicles (P &lt; 0.02) when compared with Nellore heifers, but there was no difference within groups. There was no difference in the number of primary follicles within breeds or groups. Secondary follicle numbers tended to be higher (P = 0.09) in Nellore heifers when compared with Angus heifers and was higher within groups (P &lt; 0.02), with HFC Angus and Nellore heifers having more follicles than LFC heifers. It is possible that HFC heifers have a mechanism that is developing more follicles beginning at the secondary stage, especially Nellore heifers. The development of more secondary follicles may contribute to the depletion of primordial follicles observed in Nellore heifers. This research is funded by Sao Paulo Research Foundation (FAPESP) grant #2011/50964-0. Scholarships for Favoureto, Queiroz, Loureiro, Ereno, and Pupulin are also from FAPESP.

Prostaglandin treatment at the onset of norgestomet and estradiol-based synchronization protocols did not alter the ovarian follicular dynamics or pregnancy per timed artificial insemination in cyclic Bos indicus heifers

The aim of the present study was to evaluate the effects of the PGF2α treatment given at the onset of a synchronization of ovulation protocol using a norgestomet (NORG) ear implant on ovarian follicular dynamics (Experiment 1) and pregnancy per AI (P/AI; Experiment 2) in cyclic (CL present) Bos indicus heifers. In Experiment 1, a total of 46 heifers were presynchronized using two consecutive doses of PGF2α 12 days apart. At first day of the synchronization protocol the heifers received implants containing 3mg of NORG and 2mg of estradiol benzoate (EB). At the same time, heifers were randomly assigned to receive 150mg of d-cloprostenol (n=23; PGF2α) or no additional treatment (n=23; Control). When the ear implants were removed 8 days later, all heifers received a PGF2α treatment and 1mg of EB was given 24h later. The follicular diameter and interval to ovulation were determined by transrectal ultrasonography. No effects of PGF2α treatment on the diameter of the largest follicle present were observed at implant removal (PGF2α=9.8±0.4 vs. Control=10.0±0.3mm; P=0.73) or after 24h (PGF2α=11.1±0.4 vs. Control=11.0±0.4mm; P=0.83). No differences in the time of ovulation after ear implant removal (PGF2α=70.8±1.2 vs. Control=73.3±0.9h; P=0.10) or in the ovulation rate (PGF2α=87.0 vs. Control=82.6%; P=0.64) between treatments were observed. In Experiment 2, 280 cyclic heifers were synchronized using the same experimental design described above (PGF2α; n=143 and Control; n=137), at random day of the estrous cycle. All heifers received 300 IU of equine chorionic gonadotropin (eCG) and 0.5mg of estradiol cypionate (as ovulatory stimulus) when the NORG ear implants were removed. Timed artificial insemination (TAI) was performed 48h after implant removal and the pregnancy diagnosis was conducted 30 days later. No effects on the P/AI due to PGF2α treatment were observed (PGF2α=51.7 vs. Control=57.7%; P=0.29). In conclusion, PGF2α treatment at the onset of NORG-based protocols for the synchronization of ovulation did not alter the ovarian follicular responses or the P/AI in cyclic Bos indicus beef heifers synchronized for TAI.

Lack of complete regression of the Day 5 corpus luteum after one or two doses of PGF2α in nonlactating Holstein cows

The early corpus luteum (CL) (before Day 6) does not regress after a single PGF2α treatment. We hypothesized that increasing PGF2α dose or number of treatments would allow regression of the early CL (Day 5). Nonlactating Holstein cows (N = 22) were synchronized using the Ovsynch protocol. On Day 5 (Day 0 = second GnRH treatment), cows were assigned to: (1) control (N = 5): no further treatment; (2) 1PGF (N = 6): one dose of 25 mg PGF2α; (3) 2PGF (N = 5): two doses of 25 mg PGF2α (50 mg) given 8 hours apart (second PGF2α on Day 5 at the same time as the other PGF2α treatments); (4) DPGF (N = 6): double dose of 25 mg PGF2α (50 mg) given on Day 5. Blood samples were collected to monitor progesterone (P4) profiles in two periods. In the first period (0 to 24 hours), there were effects of treatment (P = 0.01), time (P < 0.01), and an interaction of treatment and time (P = 0.02). Group 1PGF versus control was different only at 12 hours (P = 0.02). Cows treated with DPGF were different than control at 4 hours (P = 0.04), 12 hours (P < 0.01), and 24 hours (P < 0.01). Only cows treated with 2PGF had lower P4 than control during the entire period and low P4 (0.37 ± 0.17 ng/mL) at 24 hours, usually indicative of luteolysis. In the second period (Day 5 to 15 of the cycle), there were effects of treatment (P < 0.01), time (P < 0.01), and interaction of treatment and time (P = 0.002). Group 1PGF was not different than control from Day 5 to 13 and P4 was greater than control on Day 14 (P = 0.01) and 15 (P < 0.01). Circulating P4 in DPGF cows was lower than control from Day 7 (P = 0.05) through 12 (P < 0.01). Likewise, there were differences between control and 2PGF from Day 7 to 13, but not on Day 14 and 15. On Day 15, all PGF2α-treated groups had circulating P4 consistent with an active CL. Ultrasound evaluation confirmed that no CL from any group completely regressed during the experiment and no new ovulations occurred to account for functional CL later in cycle. In summary, a double dose of PGF2α (twice on Day 5 or 8 hours apart) can dramatically decrease P4, consistent with classical definitions of luteolysis; however, these CL recover and become fully functional. Thus, the Day 5 CL of mature Holstein cows do not regress even to two doses of PGF2α.

Fertility in Angus cross beef cows following 5-day CO-Synch + CIDR or 7-day CO-Synch + CIDR estrus synchronization and timed artificial insemination

The present study determined whether a 5-day CO-Synch + controlled internal drug release (CIDR) protocol with two doses of PGF2α would improve timed artificial insemination (AI) pregnancy rate compared with 7-day CO-Synch + CIDR protocol in beef cows. Angus cross beef cows (N = 1817) at 12 locations were randomly assigned to 5-day CO-Synch + CIDR or 7-day CO-Synch + CIDR groups. All cows received 100 μg of GnRH and a CIDR insert on Day 0. Cows (n = 911) in the 5-day CO-Synch + CIDR group received two doses of 25 mg PGF, the first dose given on Day 5 at CIDR removal and the second dose 6 hours later, and 100 μg GnRH on Day 8 and were inseminated concurrently, 72 hours after CIDR removal. Cows (n = 906) in 7-day CO-Synch + CIDR group received 25 mg of PGF at CIDR removal on Day 7, and 100 μg GnRH on Day 10 and were inseminated concurrently, 66 to 72 hours after CIDR removal. All cows were fitted with a heat detector aid at CIDR removal and were observed twice daily until insemination for estrus and heat detector aid status. Accounting for estrus expression at or before AI (P < 0.0001) and body condition score (P < 0.01), cows in the 5-day CO-Synch + CIDR group had greater AI pregnancy rate compared with cows in the 7-day CO-Synch + CIDR group (58.1% vs. 55.1%; P = 0.04). More cows that exhibited estrus at or before AI became pregnant compared with cows that did not [65.7% (681/1037) vs. 44.5% (347/780); P < 0.0001]. The AI pregnancy rate was lesser for cows with body condition ≤4 [≤4 − 49.3% (101/219), 5–6 − 57.9%; >6 − 55.8%]. The mean AI pregnancy rate difference between treatment groups and projected economic outcome varied among locations. In conclusion, cows synchronized with the 5-day CO-Synch + CIDR protocol had greater AI pregnancy rate than those that received the 7-day CO-Synch + CIDR protocol.

Hormonal manipulations in the 5-day timed artificial insemination protocol to optimize estrous cycle synchrony and fertility in dairy heifers

Objectives were to determine the effects of GnRH at the initiation of the 5-d timed artificial insemination (AI) program combined with 2 injections of PGF2α on ovarian responses and pregnancy per AI (P/AI) in dairy heifers, and the role of progesterone concentrations on LH release and ovulation in response to GnRH. In study 1, heifers received a controlled internal drug release (CIDR) insert containing 1.38g of progesterone on d 0, an injection of 25 mg of PGF2α and CIDR removal on d 5, and an injection of 100μg GnRH concurrently with AI on d 8. Heifers were assigned to receive no additional treatment (control; n=559) or an injection of GnRH on d 0 and a second injection of PGF2α on d 6 (G2P; n=547). In study 2, all heifers were treated as described for the control in study 1, and were allocated to receive no additional treatment (control; n=723), an injection of PGF2α on d 6 (NG2P; n=703), or an injection of GnRH on d 0 and an injection of PGF2α on d 6 (G2P; n=718). In study 3, heifers received a CIDR on d 7 after ovulation and were assigned randomly to a low-progesterone (LP; n=6) treatment in which 2 injections of 25 mg of PGF2α each were administered 12h apart, on d 7 and 7.5 after ovulation, or to a high-progesterone (HP; n=12) treatment in which no PGF2α was administered. On d 8, heifers received 100μg of GnRH and blood was sampled at every 15min from −30 to 180min relative to the GnRH for assessment of LH concentrations. Additionally, 94 heifers were assigned to LP or HP and ovulation in response to GnRH was evaluated. In study 1, P/AI was greater for G2P than for the control on d 32 (59.4 vs. 53.5%) and 60 after AI (56.6 vs. 51.3%). In study 2, administration of GnRH on d 0 increased the proportion of heifers with a new corpus luteum on d 5 (control=21.9 vs. NG2P=20.1 vs. G2P=34.4%). Administration of a second PGF2α increased the proportion of heifers with progesterone <0.5 ng/mL at AI (control=83.1 vs. NG2P=93.0 and G2P=87.2%). Pregnancy per AI was greater for G2P than for control and NG2P on d 32 (control=52.9 vs. NG2P=55.0 vs. G2P=61.7%) and 60 (control=49.0 vs. NG2P=51.6 vs. G2P=59.1%). In study 3, HP attenuated LH release and reduced ovulation (19.0 vs. 48.4%) in response to GnRH compared with LP. Combining GnRH and 2 doses of PGF2α in the 5-d timed AI protocol improved follicle turnover, luteolysis, and P/AI in heifers. Elevated concentrations of progesterone suppressed LH release and are linked with the low ovulatory response to the initial GnRH treatment of the protocol.

Luteal function, largest follicle, and fertility in postpartum dairy cows treated with 14dCIDR-PGF2α versus 2xPGF2α-Ovsynch for timed AI

A method for timed artificial insemination (AI) that is used for beef cows, beef heifers, and dairy heifers employs progesterone-releasing inserts, such as the controlled internal drug release (CIDR; Zoetis, New York, NY, USA) that are left in place for 14 days. The 14-day CIDR treatment is a method of presynchronization that ensures that cattle are in the late luteal phase of the estrous cycle when PGF2α is administered before timed AI. The objective of this study was to test the effectiveness of the 14dCIDR-PGF2α program in postpartum dairy cows by comparing it with the traditional “Presynch-Ovsynch” (2xPGF2α-Ovsynch) program. The 14dCIDR-PGF2α cows (n = 132) were treated with a CIDR insert on Day 0 for 14 days. At 19 days after CIDR removal (Day 33), the cows were treated with a luteolytic dose of PGF2α, 56 hours later were treated with an ovulatory dose of GnRH (Day 35), and 16 hours later were inseminated. The 2xPGF2α-Ovsynch cows were treated with a luteolytic dose of PGF2α on Day 0 and again on Day 14. At 12 days after the second PGF2α treatment (Day 26), the cows were treated with GnRH. At 7 days after GnRH, the cows were treated with PGF2α (Day 33), then 56 hours later treated with GnRH (Day 35), and then 16 hours later were inseminated. There was no effect of treatment or treatment by parity interaction on pregnancies per AI (P/AI) when pregnancy diagnosis was performed on Day 32 (115/263; 43.7%) or Days 60 to 90 (99/263; 37.6%) after insemination. There was an effect of parity (P < 0.05) on P/AI because primiparous cows had lesser P/AI (35/98; 35.7%) than multiparous cows (80/165; 48.5%) on Day 32. Cows observed in estrus after the presynchronization step (within 5 days after CIDR removal or within 5 days after the second PGF2α treatment) had greater P/AI than those not observed in estrus (55/103; 53.4% vs. 60/160; 37.5%; observed vs. not observed; P < 0.01; d 32 pregnancy diagnosis). When progesterone data were examined in a subset of cows (n = 208), 55.3% of cows had a “prototypical” response to treatment (i.e., the cow had an estrous cycle that was synchronized by the presynchronization treatment and then the cow responded appropriately to the subsequent PGF2α and GnRH treatments before timed AI). Collectively, cows with a prototypical response to either treatment had 52.2% P/AI that was greater (P < 0.001) than the P/AI for cows that had a nonprototypical response (19%) (P/AI determined at 60–90 days of pregnancy). In conclusion, we did not detect a difference in P/AI when postpartum dairy cows were treated with 14dCIDR-PGF2α or 2xPGF2α-Ovsynch before timed AI. The primary limitation to the success of either program was the failure of the cow to respond appropriately to the sequence of treatments.

Effect of increasing GnRH and PGF2α dose during Double-Ovsynch on ovulatory response, luteal regression, and fertility of lactating dairy cows

Ovsynch-type synchronization of ovulation protocols have suboptimal synchronization rates due to reduced ovulation to the first GnRH treatment and inadequate luteolysis to the prostaglandin F2α (PGF2α) treatment before timed artificial insemination (TAI). Our objective was to determine whether increasing the dose of the first GnRH or the PGF2α treatment during the Breeding-Ovsynch portion of Double-Ovsynch could improve the rates of ovulation and luteolysis and therefore increase pregnancies per artificial insemination (P/AI). In experiment 1, cows were randomly assigned to a two-by-two factorial design to receive either a low (L) or high (H) doses of GnRH (Gonadorelin; 100 vs. 200 μg) and a PGF2α analogue (cloprostenol; 500 vs. 750 μg) resulting in the following treatments: LL (n = 263), HL (n = 277), LH (n = 270), and HH (n = 274). Transrectal ultrasonography and serum progesterone (P4) were used to assess ovulation to GnRH1, GnRH2, and luteal regression after PGF2α during Breeding-Ovsynch in a subgroup of cows (n = 651 at each evaluation). Pregnancy status was assessed 29, 39, and 74 days after TAI. In experiment 2, cows were randomly assigned to LL (n = 220) or HH (n = 226) treatment as described for experiment 1. For experiment 1, ovulation to GnRH1 was greater (P = 0.01) for cows receiving H versus L GnRH (66.6% [217/326] vs. 57.5% [187/325]) treatment, but only for cows with elevated P4 at GnRH1. Cows that ovulated to GnRH1 had increased (P < 0.001) fertility compared with cows that did not ovulate (52.2% vs. 38.5%); however, no effect of higher dose of GnRH on fertility was detected. The greater PGF2α dose increased luteal regression primarily in multiparous cows (P = 0.03) and tended to increase fertility (P = 0.05) only at the pregnancy diagnosis 39 days after TAI. Overall, P/AI was 47.0% at 29 days and 39.7% at 74 days after TAI; P/AI did not differ (P = 0.10) among treatments at 74 days (LL, 34.6%; HL, 40.8%; LH, 42.2%; HH, 40.9%) and was greater (P < 0.001) for primiparous cows than for multiparous cows (46.1% vs. 33.8%). For experiment 2, P/AI did not differ (P = 0.21) between H versus L treatments (44.2% [100/226] vs. 40.5% [89/220]). Thus, despite an increase in ovulatory response to GnRH1 and luteal regression to PGF2α, there were only marginal effects of increasing dose of GnRH or PGF2α on fertility to TAI after Double-Ovsynch.

Effect of dinoprost and cloprostenol on serum nitric oxide and corpus luteum blood flow during luteolysis in ewes

In this study we compared the effect of dinoprost and cloprostenol on changes of corpus luteum blood flow during luteolysis. Ten nonlactating cyclic ewes were synchronized with double PGF2α injections 11 days apart. At Day 10, the animals were classified into 2 groups and received the third dose of PGF2α after confirmation of the presence of a mature CL. The first group received (12.5 mg/im) dinoprost and the second group received (250 μg/im) cloprostenol. A color Doppler ultrasound scan was performed by the same operator according to the following timeline: 0, 0.5, 1, 2, 4, 6, 12, and 24 hours, then every 24 hours until Day 4). The size, morphology, and blood flow of the CL was evaluated during the regression. The results showed that regression of the CL did not differ between the dinoprost and cloprostenol groups. There was no significant effect on diameter of the CL in both groups, though the size of the CL decreased gradually and slowly. Pretreatment progesterone concentration did not differ between groups. The results showed that the nitric oxide level was significantly increased within half an hour after the dinoprost treatment, and was significantly decreased in the cloprostenol group after half an hour. The blood velocity was increased significantly half an hour after the dinoprost treatment and it was decreased in the cloprostenol-treated group. In conclusion, both cloprostenol and dinoprost affect CL by controlling the nitric oxide level and blood supply of the CL via different mechanisms to induce luteolysis.

Effects of PGF2α on the Expression of Uterine Activation Proteins in Pregnant Human Myometrial Cells From Upper and Lower Segment

The lower and upper segments of the uterus may play different roles in the process of parturition. The switch from pregnancy to delivery involves changes in expression of uterine activation proteins (UAPs). Prostaglandin (PG) F2α has multiple and complex roles in the birth process in addition to its vital contractile role. The purpose of this study was to investigate whether PGF2α regulates the expression of UAPs in human myometrium and to compare PGF2α actions in lower and upper segments. Cultured human myometrial cells from upper and lower segments were treated with PGF2α. Western blotting was used to determine the levels of connexin 43 (CX-43), prostaglandin endoperoxide synthase-2 (PTGS-2; cyclooxygenase-2), oxytocin receptor (OTR), and PGF2α receptor (PTGFR) in the cells. The small interfering RNA approach was used to knock down PTGFR. PGF2α dose dependently increased CX-43 and PTGS-2 while decreasing PTGFR in upper and lower segments. PGF2α increased OTR in the lower segment while decreasing it in the upper segment. PGF2α lost its effects on PTGS-2 and OTR in PTGFR knockdown cells, but its effect on CX-43 remained. AL8810, a specific antagonist of PTGFR, reversed the actions of PGF2α on UAPs except for CX-43 in the lower segment. Indomethacin reversed the PGF2α-induced effects on CX-43 and PTGS-2, but it did not alter PGF2α-induced PTGFR and OTR expression. The stimulatory effects of PGF2α were enhanced in the presence of IL-1β, which reversed the inhibitory effect of PGF2α on PTGFR. PGF2α regulates UAPs in both upper and lower segment cells through either direct or indirect pathways, indicating that PGF2α uniquely participates in uterine preparation for the onset of labor.

Follicular populations and luteal function in dairy heifers treated with a controlled internal drug release insert for 14 days as a method to synchronize the estrous cycle before prostaglandin F2α treatment and artificial insemination

Progesterone-containing controlled internal drug release (CIDR) inserts are used to synchronize the estrous cycle before PGF2α is administered for timed AI (14dCIDR-PGF2α program). The program, initially designed for beef cattle, was recently shown to be efficacious in dairy heifers. We hypothesized that the 14-d CIDR treatment would synchronize the estrous cycle in dairy heifers and result in a uniformly sized corpus luteum (CL) and largest follicle (LF) at the time of PGF2α treatment. Holstein (n=110) or Holstein × Guernsey (n=4) dairy heifers were assigned to 2 treatments: (1) 14dCIDR-PGF2α [CIDR in for 14d, CIDR out for 16d, PGF2α and AI after observed estrus (n=57)] or (2) control [PGF2α and AI after observed estrus (n=57)]. Regardless of treatment, additional PGF2α injections were administered at 14-d intervals to heifers that were not seen in estrus. Ovarian ultrasonography and blood sampling were done on d 0 (CIDR administered), 14 (day CIDR removed), 19 (5d after CIDR removed), 30 (PGF2α administered), and 44 (second PGF2α dose administered to heifers that were not detected in estrus after the first PGF2α). Compared with control (untreated), more CIDR-treated heifers were categorized as having a small CL (≤9.9mm) and large LF (15.0–19.9mm) on d 14 (CIDR removal) and, as expected, a greater percentage of CIDR-treated heifers were in estrus during the 5d after the CIDR removal compared with control heifers (75.4 vs. 22.8%, respectively). On d 19, the CIDR-treated heifers had apparently ovulated based on disappearance of LF and appearance of small CL. On d 30 (PGF2α administration), 89% of 14dCIDR-PGF2α heifers had CL that were ≥20mm in diameter compared with 55% for control. Presence of larger CL on d 30 was associated with greater concentrations of plasma progesterone in 14dCIDR-PGF2α compared with control (10.5±0.5 vs. 5.0±0.6ng/mL, respectively). The percentages of heifers with LF in the smallest category (≤9.9mm) tended to be less (5.3 vs. 16.6%) and the percentage of heifers with LF in the medium-size category (10.0 to 14.9mm) tended to be greater (84.2 vs. 69.1%) for 14dCIDR-PGF2α versus control, respectively, on d 30. More heifers were detected in estrus within 5d after the first PGF2α (86.0 vs. 56.1%) and conception rate to AI using sexed semen tended to be greater (61.2% vs. 40.6%) for 14dCIDR-PGF2α compared with control (respectively). Treating dairy heifers with a CIDR for 14d was an effective method to synchronize an estrous cycle before PGF2α was administered.

Effect of progesterone concentration and duration of proestrus on fertility in beef cattle after fixed-time artificial insemination

The objective was to determine the effect of plasma progesterone concentration and the duration of proestrus during growth of the ovulatory follicle on fertility in beef cattle. Heifers (N = 61) and postpartum cows (N = 79) were assigned randomly to four groups in a two-by-two design involving luteal-phase versus subluteal-phase plasma progesterone concentrations and normal versus short proestrus. To synchronize follicular wave emergence, estradiol-17β was given im during the midluteal phase (Day 0) and concurrently, a once-used controlled intravaginal progesterone-releasing device was placed intravaginally. In the subluteal-phase progesterone groups, a luteolytic dose of PGF2α was given on Day 0 and again 12 hours later. In the luteal-phase progesterone groups, PGF2α was not given (so as to retain a functional CL). The controlled intravaginal progesterone-releasing device was removed and PGF2α was given on Days 7 or 8 in the normal- and short-proestrus groups, respectively. Cattle were given lutropin im 12 or 36 hours later in the short- and normal-proestrus groups, respectively, with AI at 12 hours after lutropin treatment. Transrectal ultrasonography was used to monitor ovarian response during treatments and to diagnose pregnancy 60 days after AI. Cattle (heifers and cows combined) in the subluteal-phase progesterone groups and normal proestrus groups had a larger follicle at the time of AI, and a larger CL that secreted more progesterone 9 days after AI than cattle with luteal-phase progesterone concentrations or those with short proestrus (P < 0.03). There was a higher incidence of ovulation (P < 0.01) the day after AI in heifers (55/61; 90%) than in cows (44/79; 56%). Pregnancy rates ranged from 11% to 54%, and were higher in cattle (heifers and cows combined) in the subluteal-phase progesterone groups and normal proestrus groups than in the luteal-phase progesterone or short proestrus groups, respectively, (P < 0.02). In conclusion, a short proestrous interval reduced pregnancy rate after fixed-time AI in beef cattle. A low progesterone environment during growth of the ovulatory follicle increased the preovulatory follicle size and subsequent CL size and function, and compensated for the effect of a short proestrus on pregnancy rates.

Administration of a GnRH analog on day 9 of a 14-day controlled internal drug release insert with timed artificial insemination in lactating beef cows1

Many estrus synchronization protocols aim to induce a new follicular wave to improve response and enhance pregnancy rate. Our objectives were to determine the effectiveness of GnRH analog administered d 0 and 9 during an extended controlled internal drug release (CIDR) protocol to produce 2 follicular waves, induce cyclicity in anestrus cows, and evaluate the efficacy of a single 50-mg dose of PGF2α to initiate luteal regression on CIDR removal. Lactating beef cows (n = 779) at 3 locations (n = 247, location 1; n = 395, location 2; n = 137, location 3) were randomly assigned to 1 of 3 treatments. Cows in the 14-d 50 PG treatment received a CIDR (1.38 g progesterone) with 100 μg GnRH analog intramuscularly (i.m.) on d 0, 100 μg GnRH analog i.m. on d 9, and CIDR removal concurrent with 50 mg PGF2α i.m. on d 14. Cows in the 14-d 6-h PG treatment were assigned the same protocol as the 14-d 50 PG treatment except that 25 mg PGF2α i.m. was given on d 14 plus 25 mg PGF2α i.m. 6 ± 1 h later. Cows in the control treatment, 5-d CO-Synch + CIDR (5-d CO-Synch), received a CIDR concurrent with 100 μg GnRH analog i.m. on d 9, CIDR removal concurrent with 25 mg PGF2α i.m. on d 14, and 25 mg PGF2α i.m. 6 ± 1 h after first F2α injection. Cows in all treatments received 100 μg GnRH analog i.m. and timed AI (TAI) 72 ± 3 h after CIDR removal. Pregnancy status to TAI was determined by ultrasonography 37 to 40 d after TAI. Averaged over all locations, pregnancy rates to TAI for 14-d 50 PG, 14-d 6-h PG, and 5-d CO-Synch treatments were 58.2%, 46.8%, and 41.9%, respectively. Pregnancy rates to TAI were greater (P < 0.05) in 14-d 50 PG treatment than 14-d 6-h PGF2α and 5-d CO-Synch treatments. Cycling status at 2 locations (n = 243, location 1; n = 391, location 2) was determined from blood collected on d -7 and 0; cows with serum progesterone concentrations >1 ng/mL at either (or both) bleeding date were considered cyclic. Averaged over the 2 locations, there was a tendency (P = 0.06) for a greater number of cyclic animals to become pregnant to TAI in the 14-d 50 PG treatment (64.4%) than 5-d CO-Synch treatment (50.2%). The 14-d CIDR with GnRH analog on d 0 and 9 and a single 50-mg dose of PG i.m. at CIDR removal was a more efficacious protocol to maximize TAI pregnancy rates than the standard 5-d CO-Synch.

176 EXPRESSION OF INSULIN-LIKE GROWTH FACTOR FAMILY MEMBERS AND GROWTH DIFFERENTIATION FACTOR 9 ON NELORE AND ANGUS HEIFERS WITH A LOW AND HIGH OVARIAN FOLLICLE COUNT

Members of the IGF family are key intra-ovarian regulators of follicle growth, selection, and atresia. Growth differentiation factor 9 (GDF9) induces follicular somatic cells to undergo mitosis and differentiation during follicular development. Cattle from Bos indicus breeds are slower to reach sexual maturity and have longer calving intervals when compared with Bos taurus breeds (Luna-Nevarez et al. 2011). On the other hand, indicine cattle have greater number of ovarian follicles recruited per oestrous cycle when compared with taurine breeds (Alvarez et al. 2000). Our objective was to evaluate the expression of IGF1, IGFR1, IGF2, and GDF9 genes in follicles dissected from Nelore and Angus heifers with high (HFC) and low (LFC) follicle counts. Eighteen Nelore heifers and 22 Angus heifers (≈24 months old) were kept on Brachiaria brizantha grass and fed with a mix of grains with minerals and water ad libitum. Oestrous cycle was synchronized with 2 doses of PGF2α 11 days apart. Heifers were scanned with an ultrasound device (US; Mindray Vet DPS 2200, São Paulo, Brazil) with a 7.5-MHz probe 1 day after ovulation for 3 consecutive oestrous cycles. Animals were slaughtered ≈24 h after ovulation of the third cycle; 3 follicles from 2 to 4 mm in diameter were dissected from the ovary contralateral to the CL. Total RNA was extracted using the RNeasy Microarray Tissue Mini Kit (Qiagen, Valencia, CA, USA). Gene expression was evaluated using oligo-dT reverse transcription, Sybr Green Master Mix and Step One Plus (AB, Foster City, CA, USA) Real-Time PCR Detection System. Samples were analysed in duplicates and CT values were normalized to the housekeeping gene PPIA using the ΔCT method. Results were analysed using the PROC MIXED procedure of SAS with follicle as the repeated measure and cow as the subject. Individual differences were analysed using contrast (SAS 9.2). The effects of group (LFC × HFC), breed, and follicle diameter on mNRA abundance were tested. Follicle LSmean was higher (P &lt; 0.05) in Nelore heifers (32 ± 3.1; LFC = 18; HFC = 52) when compared with Angus heifers (20 ± 2.6; LFC = 10; HFC = 27). Follicle diameter did not differ between breeds or groups. Expression of IGF1 and GDF9 was not different between follicles from Nelore and Angus heifers or between groups. Expression of IGFR1 was higher in follicles from Angus heifers (fold change 1.74; P &lt; 0.04) when compared with follicles derived from Nelore heifers but not different between HFC and LFC groups within each breed. Expression of IGF2 mRNA was also higher (fold change 1.70; P &lt; 0.04) in Angus heifers but not different between HFC and LFC groups within each breed. In conclusion, the higher expression of IGFR1 and IGF2 in Angus early antral follicles might be involved in important reproductive traits commonly observed in Bos taurus breeds. However, expression of IGF1, IGFR1, IGF2, and GDF9 in the follicle are not involved in the mechanisms determining different number of follicle recruited through the oestrous cycle in the same breed. This research and scholarship for Loureiro, Ereno, Favoureto, and Pupulim was from FAPESP.

171 EXPRESSION OF ANDROGEN-PRODUCING ENZYMES IN NELORE AND ANGUS HEIFERS WITH LOW AND HIGH NUMBERS OF FOLLICLES IN THE OVARY

During follicle development, androgens are synthesised by thecal cells under LH influence through the enzymatic conversion of the androgen precursors. In cattle, androgen concentration is positively correlated with the number of antral follicles. This experiment was designed to assess mRNA levels of androgen-producing enzymes (CYP11A1, CYP17A1, HSD3B, HSD17B) in Nelore and Angus heifers with high (HFC) and low follicle counts (LFC). Eighteen Nelore and 22 Angus heifers (≈24 months old) were kept on Brachiaria brizantha grass supplemented with a mix of grains. To determine the number of follicles, heifers were scanned with an ultrasound device (Mindray Vet DPS 2200, São Paulo, Brazil) with a 7.5-MHz probe 1 day after ovulation for 3 consecutive oestrous cycles. The first and third (before slaughter) oestrous cycles were synchronized with 2 doses of PGF2α 11 days apart. Animals were slaughtered ≈24 h after ovulation of the third cycle; 3 follicles from 2 to 4 mm in diameter were dissected from the ovary contralateral to the CL. Total RNA was extracted using RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Gene expression was evaluated using oligo-dT reverse transcription, Sybr Green Master Mix, and Step One Plus (AB, Foster City, CA, USA) Real-Time PCR System. Samples were analysed in duplicates, and CT values were normalized to the housekeeping gene PPIA using the ΔCT method. The ΔCT values were compared using the PROC MIXED procedure of SAS (SAS Institute Inc., Cary, NC, USA) with follicle as the repeated measure and cow as the subject. We tested the effects of breed, follicle number, and millimeters on gene expression. Individual differences between groups (HFC or LFC) within breed were analysed using the Diff function (SAS 9.2). Results were significant when P &lt; 0.05. Follicle count was higher (P &lt; 0.04) in Nelore 32 ± 3.1 (LFC = 16; HFC = 52) when compared with Angus 20 ± 2.6 (LFC = 10; HFC = 27) heifers. Follicle diameter did not differ between breeds or groups. Expression of CYP11A1 mRNA was higher in Angus heifers (P &lt; 0.01). However, there was no difference in CYP11A1 mRNA expression within groups in Angus heifers, whereas HFC Nelore heifers expressed higher levels of CYP11A1 mRNA than LFC Nelore heifers (P &lt; 0.04). Expression of CYP17A1 was not different between breeds or groups within each breed. Expression of HSD3B mRNA was higher (P &lt; 0.04) in Nelore heifers (P &lt; 0.004) when compared with follicles derived from Angus heifers but not different between HFC and LFC groups within each breed. Expression of HSD17B was higher in Nelore heifers (P &lt; 0.001) but not different between HFC and LFC groups within each breed. In conclusion, Nelore heifers had a higher expression of hydroxysteroid dehydrogenases (HSD3B and HSD17B). As androgens have been demonstrated to stimulate early follicle development (Yang and Fortune 2006 Biol. Reprod. 75, 924–932), these data are indicative that androgens may be involved in the mechanisms determining different follicle counts across cattle subspecies but not between groups within each breed. Funding and scholarship for Loureiro, Ereno, Favoureto, and Pupulim was from FAPESP.

Short communication: Presynchronization for timed artificial insemination in grazing dairy cows by using progesterone for 14 days with or without prostaglandin F2α at the time of progesterone withdrawal

Progesterone-containing devices can be inserted intravaginally for 14 d to presynchronize the estrous cycle for timed artificial insemination (TAI) in beef heifers (“14-day CIDR-PG” or “Show-Me-Synch” program). The progesterone treatment is effective for presynchronization because cattle develop a persistent dominant follicle during treatment that ovulates within 3 d after progesterone removal. The subsequent estrous cycle can be effectively used for a TAI program. Some cattle will retain a functional corpus luteum (CL) for the entire 14-d treatment period and will not be synchronized effectively because the interval to ovulation depends on the lifespan of their existing CL. The objective was to test the effect of a luteolytic dose of PGF2α at progesterone removal for improving synchrony of estrus after treatment and increasing conception rate to a subsequent TAI in dairy cows. Postpartum cows (n = 1,021) from 2 grazing dairy herds were assigned to 1 of 2 presynchronization programs that used a controlled internal drug releasing (CIDR) device containing progesterone: 14dCIDR (CIDR in, 14 d, CIDR out; n = 523) or 14dCIDR+PGF2α (CIDR in, 14 d, CIDR out, and PGF2α; n = 498). Cows were body condition scored (BCS; 1 to 5, thin to fat) and tail painted at CIDR removal. Paint score (PS) was recorded after CIDR removal [PS = 0 (all paint removed, indication of estrus), PS = 3 (paint partially removed), or PS = 5 (no paint removed; indication of no estrus)]. At 19 d after CIDR removal, all cows were treated with PGF2α, 56 h later treated with GnRH, and then 16 h later were TAI. Treating cows with PGF2α at CIDR removal increased the percentage with PS = 0 within 5 d (58.1% vs. 68.9%; 14dCIDR vs. 14dCIDR+PGF2α). We found no effect of treatment, however, on conception rate at TAI (41.1% vs. 43.6%; respectively). The TAI conception rate increased with increasing BCS and was greater for cows that had PS = 0 within 5 d after CIDR removal. In summary, treating cows with PGF2α at CIDR removal increased the percentage of cows with all tail paint removed but did not increase percentage of pregnant cows after TAI.

Effects of d-cloprostenol dose and corpus luteum age on ovulation, luteal function, and morphology in nonlactating dairy cows with early corpora lutea

Luteolysis is a key event in cattle reproduction. A standard dose of exogenous PGF2α will induce full luteolysis in the majority of cows with a matured corpus luteum (CL). However, this will not occur in cows with a CL <5d old. To date, it is not known whether a larger dose will have a more potent luteolytic effect in cows during early diestrus. The objective of this study was to characterize the effect of 2 doses of d-cloprostenol (150 and 300μg) on the progesterone concentration, luteal diameter, and ovulation rate in nonlactating dairy cattle 96 to 132h postovulation. Twenty nonlactating dairy cows were included in the study. Each cow received 2 treatments of d-cloprostenol in 2 consecutive cycles: a standard dose of 150μg and a double dose of 300μg. The cows were allocated randomly to 1 of 4 groups (5 cows in each group) according to the age of the CL at the time of treatment: 96, 108, 120, and 132h. The exact time of ovulation was known within 12h, because of twice per day ultrasound examination. The CL diameter and progesterone concentration were measured before treatment (d 0) and 2 and 4d after treatment. Within each CL age group, the effect of d-cloprostenol dose on luteolysis was determined. More cows treated with double dose tended to have full luteolysis compared with the standard dose (8/10 vs. 4/10, respectively). This effect was only apparent in cows with CL of 120 and 132h but not in earlier CL. The interval from treatment to ovulation was shorter (3.3±0.1d) in cows treated with a double dose than in cows treated with the standard dose (4.5±0.4d).

Luteolysis after the intravulvosubmucosal injection of prostaglandin F2α in cattle: Systemic or local mechanism?

The intravulvosubmucosal (IVSM) route has been used to reduce the dose of prostaglandin F2α (PGF2α), a luteolytic agent used in estrus synchronization programs. To validate the effectiveness of PGF2α administered via IVSM, the estrus rate was monitored in 1937 beef cows for 5 days (25.6% of estrus). The cows that did not show signs of estrus by day 5 received 5mg of dinoprost IVSM (1/5 of the standard dose; n=1440). By day 10, 68.2% of the cows were in estrus. In a second trial, using the same synchronization protocol, the proportion of heifers in estrus after receiving 5mg dinoprost at day 5 via IVSM (47.4%; n=97) or via an intramuscular injection (IM; 54.7%; n=95) did not differ (P>0.05). The occurrence of luteolysis (serum progesterone concentrations below 1ng/mL) was dependent on the period of the estrous cycle in which the cows were treated with 5mg of dinoprost via IM or IVSM. Luteolysis was observed in 5 out of 10 cows treated at day 10 but was not observed in any cows treated at day 5 of the estrous cycle. Luteolysis occurred in all animals treated with 25mg dinoprost independent of the estrous cycle period (day 5 or 10). After IVSM injection, the PGF2α concentration did not differ in the uterine and jugular veins. This was further confirmed by measuring the concentration of 13,14-dihydro-15-keto-PGF2α (PGFM) after the injection of 5mg of dinoprost via the IM or IVSM route. Dinoprost IM and IVSM injections resulted in a similar PGFM serum pattern over time, indicating the same rate of absorption into the systemic circulation. Taking the results together, we concluded that PGF2α IVSM injections reached the systemic circulation before reaching the ovary, and the effectiveness of low doses of PGF2α was dependent on the period of the estrous cycle and not on the route of administration.